Platelet-rich fibrin (PRF) works by concentrating your own blood’s healing components into a fibrin scaffold that slowly releases growth factors over roughly 10 days. A small blood sample is drawn and spun in a centrifuge without any additives. The spinning separates the blood into layers, and the middle layer forms a dense fibrin matrix packed with platelets, white blood cells, and proteins that drive tissue repair.
How the Fibrin Matrix Forms
Unlike its predecessor, platelet-rich plasma (PRP), PRF is made without anticoagulants or chemical activators. When blood is drawn into a plain tube and centrifuged, it begins clotting naturally during the spin. The fibrinogen in your blood converts into fibrin, creating a three-dimensional scaffold that traps platelets and immune cells throughout the material. This natural clotting process is the key difference: the fibrin network acts like a slow-release delivery system for growth factors rather than dumping them all at once.
PRP, by contrast, uses anticoagulants during processing and then requires chemical activation to trigger clotting. That activation causes roughly 95% of the growth factors to be released almost immediately. PRF’s gradual, natural clotting means its growth factors are woven into the fibrin structure and released steadily as the matrix breaks down in your body.
The Growth Factors Behind the Healing
PRF releases at least five key signaling proteins that orchestrate tissue repair. These include proteins that stimulate new blood vessel formation (VEGF), promote cell growth and division (EGF and PDGF), regulate inflammation and scarring (TGF-β1), and help remodel tissue architecture (MMP-9). Lab studies measuring these proteins found that both liquid and solid forms of PRF continue releasing them for at least 10 days, providing a sustained signal to surrounding cells to regenerate.
This extended release window matters because healing isn’t a one-time event. Tissue repair happens in overlapping stages: inflammation, new cell growth, and remodeling. A scaffold that feeds growth factors into the site over a week and a half can support multiple phases of that process rather than front-loading everything into the first few hours.
How PRF Is Prepared
The procedure starts with a standard blood draw, typically one to several tubes depending on the application. Those tubes go into a tabletop centrifuge in the treatment room. Spin speeds and times vary by the type of PRF being made. A common protocol for advanced PRF (A-PRF) uses about 1,500 RPM for 14 minutes, while a newer variation called A-PRF+ uses a lower speed of around 1,300 RPM for 8 minutes. Lower centrifugation forces tend to preserve more white blood cells and platelets in the final product.
After spinning, the tube separates into three visible layers: red blood cells at the bottom, a golden fibrin clot in the middle, and a small amount of cell-poor plasma on top. The clinician removes the fibrin clot, which can be used as a solid membrane, compressed into a plug, or, in liquid PRF protocols, collected before it fully sets. The entire preparation takes under 20 minutes and happens chairside, so the material is used fresh.
PRF in Dental and Oral Surgery
Dentistry is where PRF has the strongest track record. After a tooth extraction, placing PRF in the empty socket reduces bone loss by about 1.2 mm compared to letting the socket heal on its own. That preserved bone matters because it determines whether the site can support a future implant without additional grafting procedures.
When combined with bone graft materials, PRF can cut healing time significantly. One randomized trial found that adding PRF to a bovine bone graft achieved the same amount of new bone formation in four months that the graft alone took eight months to reach. For large bone defects, though, PRF alone doesn’t replace traditional grafts. A meta-analysis showed PRF by itself produced about 12% less bone volume than standard grafting materials in those cases. The sweet spot appears to be using PRF as a booster alongside grafts rather than as a standalone replacement for major bone reconstruction.
Wound Healing Applications
PRF has shown striking results in chronic wounds that resist conventional treatment. In a study of chronic lower-limb ulcers, wounds treated with PRF shrank by an average of 89.3% over six weeks. The comparison group, treated with normal saline dressings, saw only 16.5% reduction in the same period. Among the ulcers that fully closed, the average healing time was about 6.5 weeks. Notably, the presence of diabetes did not significantly affect PRF’s healing performance in that study, which is relevant since diabetic foot ulcers are among the most stubborn chronic wounds.
The mechanism here involves PRF’s growth factors stimulating new blood vessel growth into the wound bed, promoting skin cell migration across the wound surface, and modulating the inflammatory environment that often keeps chronic wounds stuck in a non-healing state.
Skin Rejuvenation and Aesthetics
PRF has entered the aesthetics world as an alternative to PRP-based “vampire facials.” When injected into the skin or applied after microneedling, PRF’s sustained growth factor release stimulates collagen production and increases skin thickness over time. Thicker, more collagen-rich skin shows less visible pigmentation, which is why some studies have noted reduced dark spots around the eyes and improved texture after PRF treatments. Results develop gradually over weeks to months as the collagen remodeling process unfolds, and most protocols call for a series of sessions rather than a single treatment.
Why It Uses Your Own Blood
Because PRF is made entirely from your own blood with no additives, the risk of allergic reaction or rejection is essentially zero. There are no synthetic chemicals, no bovine proteins, and no foreign materials involved. This autologous (self-derived) nature is also why PRF sits in a unique regulatory space. The FDA clears the centrifuge devices used to prepare platelet concentrates at the point of care, and multiple such systems received clearance in 2025 alone. The procedure itself, however, is practiced under a clinician’s medical judgment rather than requiring separate drug approval, since the material never leaves the treatment room and is never altered with outside substances.
The main practical limitation is that PRF must be used quickly after preparation. Solid PRF begins to degrade within a couple of hours, and liquid PRF will clot if not applied promptly. This means it can’t be stored, shipped, or mass-produced. Every treatment requires a fresh blood draw and on-site processing.